Niacin is still beneficial. Implications from an updated meta-regression analysis.
D
D
Siniawski
C G
CG
Santos-Gallego
J J
JJ
Badimon
W M
WM
Masson
D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000378:metabolism / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D002986:Clinical Trials as Topic; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology; D009525:Niacin / Q000494:pharmacology*; D012307:Risk Factors; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood*
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D014280:Triglycerides; D009525:Niacin
HDL-C; Niacin; meta-analysis; nicotinic acid; non HDL-C; triglycerides